AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
410 W. Harrison, Seattle, WA 98119-4007, (206) 281-7001
NeoRx Corp. develops targeted biopharmaceutical products that detect and treat human illnesses, with a primary focus on cancer.
The company was started in 1984, and its initial public offering was held in August 1988.
Value Number of shares outstanding (Dec. 23, 1992) 29,312,776 Price (April 30, 1993) $2.44 Market capitalization $71,000,000